Blessie Nelson

14PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Atmospheric aerosolsMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Blessie Elizabeth Nelson, Filip Janku, Siqing Fu

|Feb 01, 2024
Predicting the Abscopal Phenomenon-Reply.

Blessie Elizabeth Nelson, Vivek Subbiah

|Jun 13, 2023
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.

Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu

|Jun 01, 2023
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers.

Blessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth

|May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.

Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse

Pageof 3